Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

Role of artificial intelligence in the care of patients with nonsmall cell lung cancer INTRODUCTIONLung cancer remains the most frequently diagnosed cancer and a leading cause of cancer‐related mortality worldwide. Due to late presentation of clinical symptoms and limited screening programmes, as many as 57% of patients diagnosed with lung cancer present with metastasis. Histologically, approximately 85% of all new lung cancer cases are classified as nonsmall cell lung cancers (NSCLC), 10% are small cell lung cancer (SCLC) and 5% account for other variants.Most NSCLC can be grouped into 3 main categories: Squamous Cell Carcinoma, Adenocarcinoma and Large Cell Carcinoma histo‐subtypes. Besides histological, clinical and demographic information, a wide range of data ranging from genomics, proteomics, immunohistochemistry and imaging must be integrated by physicians when developing personalized treatment plans for patients which can be challenging and lead to unfavourable outcomes. Furthermore, there are a number of factors that limit timely access to these tests, including high cost and late availability in the patient care continuum.This has led to an interest in developing computational approaches such as machine learning (ML), a subfield of artificial intelligence (AI), to improve medical management by providing insights that improve patient outcomes and workflow throughout a patient's journey. ML is the analysis and interpretation of data by machine algorithms http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

Loading next page...
 
/lp/wiley/role-of-artificial-intelligence-in-the-care-of-patients-with-nonsmall-zfSfLo5iOZ
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12901
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONLung cancer remains the most frequently diagnosed cancer and a leading cause of cancer‐related mortality worldwide. Due to late presentation of clinical symptoms and limited screening programmes, as many as 57% of patients diagnosed with lung cancer present with metastasis. Histologically, approximately 85% of all new lung cancer cases are classified as nonsmall cell lung cancers (NSCLC), 10% are small cell lung cancer (SCLC) and 5% account for other variants.Most NSCLC can be grouped into 3 main categories: Squamous Cell Carcinoma, Adenocarcinoma and Large Cell Carcinoma histo‐subtypes. Besides histological, clinical and demographic information, a wide range of data ranging from genomics, proteomics, immunohistochemistry and imaging must be integrated by physicians when developing personalized treatment plans for patients which can be challenging and lead to unfavourable outcomes. Furthermore, there are a number of factors that limit timely access to these tests, including high cost and late availability in the patient care continuum.This has led to an interest in developing computational approaches such as machine learning (ML), a subfield of artificial intelligence (AI), to improve medical management by providing insights that improve patient outcomes and workflow throughout a patient's journey. ML is the analysis and interpretation of data by machine algorithms

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial